Andrea Paul
CIK: 0001863130
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ZNTL
Zentalis Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
About Paul Andrea
Paul Andrea (SEC CIK 0001863130) files insider reports with the SEC as Chief Legal Officer of Zentalis Pharmaceuticals, Inc. (ZNTL).
Signal8 holds 1 ownership filing by Paul Andrea, a Form 4, filed on Feb 5, 2025. Those filings report 2 transactions, the latest on Feb 3, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Paul Andrea's filings is in SAN DIEGO, CA.
Recent filings by Paul Andrea
Other insiders filing for Zentalis Pharmaceuticals, Inc. (ZNTL)
- Bruns Ingmar, Chief Medical Officer
- WALTERS GROUP, 10% Owner
- Johnson David Michael, Director
- Skvarka Jan, Director
- Walker Luke Nathaniel, Director
- Kariuki Enoch, Director